Biovica’s CEO and main shareholder lends shares for redemption of option program

2021-01-12 11:50

Biovica's CEO and main shareholder Anders Rylander has, to facilitate the administration of the company's warrant program 3, lent 127,000 shares to Pareto Securities AB.

The program comprises 200,000 options, of which 145,000 options have been transferred. An option gives the right to subscribe for one share for SEK 20.93 and the subscription period runs through August 25, 2021. The transaction has today been registered in Finansinspektionen's register for insider trading.
The shares will be returned when Biovica has issued new shares and the new share issue has been registered with the Swedish Companies Registration Office (Bolagsverket).


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program